The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 18, 2021
Filed:
Apr. 03, 2019
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Jeannie M. Ziff, San Diego, CA (US);
Cathy Preville, San Diego, CA (US);
Brock T. Shireman, Poway, CA (US);
Assignee:
JANSSEN PHARMACEUTICA NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/04 (2006.01); C07D 401/14 (2006.01); A61K 31/4545 (2006.01); A61P 25/24 (2006.01); C07D 401/12 (2006.01); A61P 25/18 (2006.01); C07D 213/89 (2006.01); C07D 213/68 (2006.01); C07D 239/42 (2006.01); C07D 403/04 (2006.01); C07D 471/10 (2006.01); C07D 213/74 (2006.01); C07D 487/10 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61P 25/18 (2018.01); A61P 25/24 (2018.01); C07D 213/68 (2013.01); C07D 213/74 (2013.01); C07D 213/89 (2013.01); C07D 239/42 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 471/10 (2013.01); C07D 487/10 (2013.01);
Abstract
Substituted pyrimidine and pyridines as NR2B receptor ligands, for example Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.